{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T18:52:42Z","timestamp":1789066362944,"version":"build-2803163510"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:00:00Z","timestamp":1721001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81760400"],"award-info":[{"award-number":["81760400"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002338","name":"Ministry of Education of the People's Republic of China","doi-asserted-by":"publisher","award":["2020-39"],"award-info":[{"award-number":["2020-39"]}],"id":[{"id":"10.13039\/501100002338","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jgar.2024.07.007","type":"journal-article","created":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T23:29:15Z","timestamp":1724110155000},"page":"12-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Phage therapy for bone and joint infections: A comprehensive exploration of challenges, dynamics, and therapeutic prospects"],"prefix":"10.1016","volume":"39","author":[{"given":"Jiaze","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caopei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengbing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuyin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianpeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiachen","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2024.07.007_bib0001","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1302\/0301-620X.104B11.BJJ-2022-0944","article-title":"Periprosthetic joint infection: what next?","volume":"104-b","author":"Rajput","year":"2022","journal-title":"Bone Joint J"},{"key":"10.1016\/j.jgar.2024.07.007_bib0002","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0140-6736(14)61798-0","article-title":"Periprosthetic joint infection","volume":"387","author":"Kapadia","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jgar.2024.07.007_bib0003","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.medmal.2018.02.004","article-title":"Key features of bone and joint infections following the implementation of reference centers in France","volume":"48","author":"Laurent","year":"2018","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.jgar.2024.07.007_bib0004","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/MS9.0000000000000430","article-title":"The rate and management of prosthetic joint infection in the low-income setting: a cross-sectional study","volume":"85","author":"Hafez","year":"2023","journal-title":"Ann Med Surg (Lond)"},{"key":"10.1016\/j.jgar.2024.07.007_bib0005","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1128\/CMR.00111-13","article-title":"Prosthetic joint infection","volume":"27","author":"Tande","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jgar.2024.07.007_bib0006","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/cid\/cis746","article-title":"A large multicenter study of methicillin-susceptible and methicillin-resistant Staphylococcus aureus prosthetic joint infections managed with implant retention","volume":"56","author":"Lora-Tamayo","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2024.07.007_bib0007","doi-asserted-by":"crossref","first-page":"26522","DOI":"10.1038\/srep26522","article-title":"Diverse genetic background of multidrug-resistant Pseudomonas aeruginosa from Mainland China, and emergence of an extensively drug-resistant ST292 clone in Kunming","volume":"6","author":"Fan","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jgar.2024.07.007_bib0008","first-page":"3357","article-title":"Osteoarticular infection caused by MDR Pseudomonas aeruginosa: the benefits of combination therapy with colistin plus \u03b2-lactams","volume":"70","author":"Ribera","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2024.07.007_bib0009","doi-asserted-by":"crossref","first-page":"5958","DOI":"10.3390\/ijms23115958","article-title":"Colonization and infection of indwelling medical devices by Staphylococcus aureus with an emphasis on orthopedic implants","volume":"23","author":"Pietrocola","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jgar.2024.07.007_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41522-016-0007-9","article-title":"Evolutionary adaptations of biofilms infecting cystic fibrosis lungs promote mechanical toughness by adjusting polysaccharide production","volume":"3","author":"Kovach","year":"2017","journal-title":"NPJ Biofilms Microbiomes"},{"key":"10.1016\/j.jgar.2024.07.007_bib0011","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1001\/jama.296.2.202","article-title":"Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media","volume":"296","author":"Hall-Stoodley","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jgar.2024.07.007_bib0012","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1016\/S1473-3099(21)00612-5","article-title":"Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review","volume":"22","author":"Uyttebroek","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jgar.2024.07.007_bib0013","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/nature09354","article-title":"Bacterial charity work leads to population-wide resistance","volume":"467","author":"Lee","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jgar.2024.07.007_bib0014","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cmi.2020.04.039","article-title":"Pharmacokinetics\/pharmacodynamics of antipseudomonal bacteriophage therapy in rats: a proof-of-concept study","volume":"26","author":"Lin","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2024.07.007_bib0015","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1146\/annurev.micro.55.1.437","article-title":"Bacteriophage therapy","volume":"55","author":"Summers","year":"2001","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.jgar.2024.07.007_bib0016","doi-asserted-by":"crossref","first-page":"10400","DOI":"10.1073\/pnas.1601060113","article-title":"Healthy human gut phageome","volume":"113","author":"Manrique","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jgar.2024.07.007_bib0017","doi-asserted-by":"crossref","first-page":"ofaa389","DOI":"10.1093\/ofid\/ofaa389","article-title":"Lessons learned from the first 10 consecutive cases of intravenous bacteriophage therapy to treat multidrug-resistant bacterial infections at a single center in the United States","volume":"7","author":"Aslam","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jgar.2024.07.007_bib0018","doi-asserted-by":"crossref","first-page":"156074","DOI":"10.1016\/j.scitotenv.2022.156074","article-title":"Diversity of lytic bacteriophages against XDR Klebsiella pneumoniae sequence type 16 recovered from sewage samples in different parts of the world","volume":"839","author":"Martins","year":"2022","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.jgar.2024.07.007_bib0019","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1128\/AEM.01311-12","article-title":"Prophage carriage and diversity within clinically relevant strains of Clostridium difficile","volume":"78","author":"Shan","year":"2012","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.jgar.2024.07.007_bib0020","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.molcel.2013.02.002","article-title":"Discovery of functional toxin\/antitoxin systems in bacteria by shotgun cloning","volume":"50","author":"Sberro","year":"2013","journal-title":"Mol Cell"},{"key":"10.1016\/j.jgar.2024.07.007_bib0021","doi-asserted-by":"crossref","first-page":"9642","DOI":"10.1038\/s41598-018-27716-3","article-title":"Temperature-dependent virus lifecycle choices may reveal and predict facets of the biology of opportunistic pathogenic bacteria","volume":"8","author":"Egilmez","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jgar.2024.07.007_bib0022","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.mib.2013.08.008","article-title":"Phage lysis: do we have the hole story yet?","volume":"16","author":"Young","year":"2013","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.jgar.2024.07.007_bib0023","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nature21049","article-title":"Communication between viruses guides lysis-lysogeny decisions","volume":"541","author":"Erez","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jgar.2024.07.007_bib0024","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cell.2022.11.017","article-title":"Phage therapy: from biological mechanisms to future directions","volume":"186","author":"Strathdee","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.jgar.2024.07.007_bib0025","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3390\/v10060310","article-title":"Development of phage lysins as novel therapeutics: a historical perspective","volume":"10","author":"Fischetti","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.jgar.2024.07.007_bib0026","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1126\/science.1066869","article-title":"Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase","volume":"294","author":"Loeffler","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.jgar.2024.07.007_bib0027","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/1751-7915.12166","article-title":"Construction of a chimeric lysin Ply187N-V12C with extended lytic activity against staphylococci and streptococci","volume":"8","author":"Dong","year":"2015","journal-title":"Microb Biotechnol"},{"key":"10.1016\/j.jgar.2024.07.007_bib0028","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nrmicro2315","article-title":"Bacteriophage resistance mechanisms","volume":"8","author":"Labrie","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jgar.2024.07.007_bib0029","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.3390\/v14122617","article-title":"How interest in phages has bloomed into a leading medical research activity in Poland","volume":"14","author":"\u017baczek","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.jgar.2024.07.007_bib0030","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/cid\/civ067","article-title":"Multicenter surveillance of Streptococcus pneumoniae isolates from middle ear and mastoid cultures in the 13-valent pneumococcal conjugate vaccine era","volume":"60","author":"Kaplan","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2024.07.007_bib0031","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4103\/0971-5916.178615","article-title":"Phage therapy of staphylococcal chronic osteomyelitis in experimental animal model","volume":"143","author":"Kishor","year":"2016","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.jgar.2024.07.007_bib0032","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2106\/JBJS.K.01135","article-title":"Bacteriophage therapy in implant-related infections: an experimental study","volume":"95","author":"Yilmaz","year":"2013","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.jgar.2024.07.007_bib0033","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jbm.a.36790","article-title":"Bacteriophage delivering hydrogels reduce biofilm formation in vitro and infection in vivo","volume":"108","author":"Wroe","year":"2020","journal-title":"J Biomed Mater Res A"},{"key":"10.1016\/j.jgar.2024.07.007_bib0034","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/1471-2180-9-169","article-title":"Effects of prophylactic administration of bacteriophages to immunosuppressed mice infected with Staphylococcus aureus","volume":"9","author":"Zimecki","year":"2009","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.jgar.2024.07.007_bib0035","doi-asserted-by":"crossref","first-page":"e00117","DOI":"10.1128\/AAC.00117-21","article-title":"Activity of lysin CF-296 alone and in addition to daptomycin in a rat model of experimental methicillin-resistant Staphylococcus aureus osteomyelitis","volume":"65","author":"Karau","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2024.07.007_bib0036","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01235-19","article-title":"Exebacase in addition to daptomycin is more active than daptomycin or exebacase alone in methicillin-resistant Staphylococcus aureus osteomyelitis in rats","volume":"63","author":"Karau","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2024.07.007_bib0037","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1128\/AAC.02526-12","article-title":"Novel bacteriophage lysin with broad lytic activity protects against mixed infection by Streptococcus pyogenes and methicillin-resistant Staphylococcus aureus","volume":"57","author":"Gilmer","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2024.07.007_bib0038","doi-asserted-by":"crossref","first-page":"e02231","DOI":"10.1128\/AAC.02231-19","article-title":"Evaluation of the activity of a combination of three bacteriophages alone or in association with antibiotics on Staphylococcus aureus embedded in biofilm or internalized in osteoblasts","volume":"64","author":"Kolenda","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2024.07.007_bib0039","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3390\/antibiotics9110749","article-title":"Adjunctive use of phage Sb-1 in antibiotics enhances inhibitory biofilm growth activity versus rifampin-resistant Staphylococcus aureus strains","volume":"9","author":"Wang","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.jgar.2024.07.007_bib0040","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3390\/v9110315","article-title":"Differential effect of newly isolated phages belonging to PB1-like, phiKZ-Like and LUZ24-like viruses against multi-drug resistant Pseudomonas aeruginosa under varying growth conditions","volume":"9","author":"Latz","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.jgar.2024.07.007_bib0041","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.copbio.2021.02.002","article-title":"Targeting biofilms using phages and their enzymes","volume":"68","author":"Azeredo","year":"2021","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.jgar.2024.07.007_bib0042","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/08927014.2015.1131821","article-title":"Discrimination of bacteriophage infected cells using locked nucleic acid fluorescent in situ hybridization (LNA-FISH)","volume":"32","author":"Vilas Boas","year":"2016","journal-title":"Biofouling"},{"key":"10.1016\/j.jgar.2024.07.007_bib0043","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1128\/AEM.02304-07","article-title":"Fluorescence correlation spectroscopy to study diffusion and reaction of bacteriophages inside biofilms","volume":"74","author":"Briandet","year":"2008","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.jgar.2024.07.007_bib0044","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.3390\/antibiotics10121497","article-title":"Treating bacterial infections with bacteriophage-based enzybiotics: in vitro, in vivo and clinical application","volume":"10","author":"Danis-Wlodarczyk","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.jgar.2024.07.007_bib0045","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.ijantimicag.2018.09.006","article-title":"Bacteriophage Sb-1 enhances antibiotic activity against biofilm, degrades exopolysaccharide matrix and targets persisters of Staphylococcus aureus","volume":"52","author":"Tkhilaishvili","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2024.07.007_bib0046","doi-asserted-by":"crossref","first-page":"e00061","DOI":"10.1128\/mBio.00061-13","article-title":"A multifaceted study of Pseudomonas aeruginosa shutdown by virulent podovirus LUZ19","volume":"4","author":"Lavigne","year":"2013","journal-title":"MBio"},{"key":"10.1016\/j.jgar.2024.07.007_bib0047","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1128\/JVI.01930-07","article-title":"Global transcriptional responses of Pseudomonas aeruginosa to phage PRR1 infection","volume":"82","author":"Ravantti","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.jgar.2024.07.007_bib0048","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3109\/1040841X.2012.723675","article-title":"Bacteriophage virion-associated peptidoglycan hydrolases: potential new enzybiotics","volume":"39","author":"Rodr\u00edguez-Rubio","year":"2013","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.jgar.2024.07.007_bib0049","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107307","article-title":"Effective removal of staphylococcal biofilms by the endolysin LysH5","volume":"9","author":"Guti\u00e9rrez","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2024.07.007_bib0050","doi-asserted-by":"crossref","first-page":"e02666","DOI":"10.1128\/AAC.02666-16","article-title":"Bacteriophage lysin CF-301, a potent antistaphylococcal biofilm agent","volume":"61","author":"Schuch","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2024.07.007_bib0051","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1302\/0301-620X.102B7.BJJ-2019-1590.R1","article-title":"John Charnley Award: the antimicrobial potential of bacteriophage-derived lysin in a murine debridement, antibiotics, and implant retention model of prosthetic joint infection","volume":"102-b","author":"Sosa","year":"2020","journal-title":"Bone Joint J"},{"key":"10.1016\/j.jgar.2024.07.007_bib0052","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/jac\/dkv038","article-title":"A novel chimeric phage lysin with high in vitro and in vivo bactericidal activity against Streptococcus pneumoniae","volume":"70","author":"D\u00edez-Mart\u00ednez","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2024.07.007_bib0053","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1128\/AAC.00492-11","article-title":"In vitro destruction of Streptococcus pneumoniae biofilms with bacterial and phage peptidoglycan hydrolases","volume":"55","author":"Domenech","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2024.07.007_bib0054","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1128\/AEM.00096-15","article-title":"Targeting Enterococcus faecalis biofilms with phage therapy","volume":"81","author":"Khalifa","year":"2015","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.jgar.2024.07.007_bib0055","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jgar.2019.10.019","article-title":"The lytic bacteriophage vB_EfaH_EF1TV, a new member of the Herelleviridae family, disrupts biofilm produced by Enterococcus faecalis clinical strains","volume":"21","author":"D\u2019Andrea","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.jgar.2024.07.007_bib0056","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180838","article-title":"Environmental bacteriophages active on biofilms and planktonic forms of toxigenic Vibrio cholerae: potential relevance in cholera epidemiology","volume":"12","author":"Naser","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2024.07.007_bib0057","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.3382\/ps\/pex124","article-title":"Bacteriophage use to control Salmonella biofilm on surfaces present in chicken slaughterhouses","volume":"96","author":"de Ornellas Dutka Garcia","year":"2017","journal-title":"Poult Sci"},{"key":"10.1016\/j.jgar.2024.07.007_bib0058","doi-asserted-by":"crossref","first-page":"e15678","DOI":"10.1371\/journal.pone.0015678","article-title":"Prophage spontaneous activation promotes DNA release enhancing biofilm formation in Streptococcus pneumoniae","volume":"5","author":"Carrolo","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2024.07.007_bib0059","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1128\/AEM.72.1.956-959.2006","article-title":"Emergence of biofilm-forming subpopulations upon exposure of Escherichia coli to environmental bacteriophages","volume":"72","author":"Lacqua","year":"2006","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.jgar.2024.07.007_bib0060","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01851-22","article-title":"Phage-plasmids spread antibiotic resistance genes through infection and lysogenic conversion","volume":"13","author":"Pfeifer","year":"2022","journal-title":"MBio"},{"key":"10.1016\/j.jgar.2024.07.007_bib0061","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3390\/antibiotics9050241","article-title":"Salvage bacteriophage therapy for a chronic MRSA prosthetic joint infection","volume":"9","author":"Doub","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.jgar.2024.07.007_bib0062","doi-asserted-by":"crossref","first-page":"ofy269","DOI":"10.1093\/ofid\/ofy269","article-title":"Salvage debridement, antibiotics and implant retention (\u201cDAIR\u201d) with local injection of a selected cocktail of bacteriophages: is it an option for an elderly patient with relapsing Staphylococcus aureus prosthetic-joint infection?","volume":"5","author":"Ferry","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jgar.2024.07.007_bib0063","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1038\/s41467-022-31837-9","article-title":"Personalized bacteriophage therapy to treat pandrug-resistant spinal Pseudomonas aeruginosa infection","volume":"13","author":"Ferry","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.jgar.2024.07.007_bib0064","doi-asserted-by":"crossref","first-page":"e00924","DOI":"10.1128\/AAC.00924-19","article-title":"Bacteriophages as adjuvant to antibiotics for the treatment of periprosthetic joint infection caused by multidrug-resistant Pseudomonas aeruginosa","volume":"64","author":"Tkhilaishvili","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2024.07.007_bib0065","doi-asserted-by":"crossref","first-page":"550853","DOI":"10.3389\/fmed.2021.550853","article-title":"Arthroscopic \u201cDebridement and implant retention\u201d with local administration of exebacase (lysin CF-301) followed by suppressive tedizolid as salvage therapy in elderly patients for relapsing multidrug-resistant S. epidermidis prosthetic knee infection","volume":"8","author":"Ferry","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jgar.2024.07.007_bib0066","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1172\/JCI136577","article-title":"Exebacase for patients with Staphylococcus aureus bloodstream infection and endocarditis","volume":"130","author":"Fowler","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jgar.2024.07.007_bib0067","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.3390\/v13101898","article-title":"A case of in situ phage therapy against Staphylococcus aureus in a bone allograft polymicrobial biofilm infection: outcomes and phage-antibiotic interactions","volume":"13","author":"Van Nieuwenhuyse","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.jgar.2024.07.007_bib0068","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3390\/v11100891","article-title":"Bacteriophage application for difficult-to-treat musculoskeletal infections: development of a standardized multidisciplinary treatment protocol","volume":"11","author":"Onsea","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.jgar.2024.07.007_bib0069","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1093\/cid\/ciz222","article-title":"Successful treatment of antibiotic-resistant, poly-microbial bone infection with bacteriophages and antibiotics combination","volume":"69","author":"Nir-Paz","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2024.07.007_bib0070","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3390\/antibiotics7040087","article-title":"Resolving digital staphylococcal osteomyelitis using bacteriophage\u2014a case report","volume":"7","author":"Fish","year":"2018","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.jgar.2024.07.007_bib0071","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/s41467-021-27656-z","article-title":"Combination of pre-adapted bacteriophage therapy and antibiotics for treatment of fracture-related infection due to pandrug-resistant Klebsiella pneumoniae","volume":"13","author":"Eskenazi","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.jgar.2024.07.007_bib0072","doi-asserted-by":"crossref","first-page":"851310","DOI":"10.3389\/fmed.2022.851310","article-title":"Use of phage cocktail BFC 1.10 in combination with ceftazidime-avibactam in the treatment of multidrug-resistant Pseudomonas aeruginosa femur osteomyelitis\u2014a case report","volume":"9","author":"Racenis","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jgar.2024.07.007_bib0073","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3390\/antibiotics9110795","article-title":"The safety and efficacy of phage therapy for bone and joint infections: a systematic review","volume":"9","author":"Clarke","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.jgar.2024.07.007_bib0074","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1302\/2058-5241.6.210073","article-title":"A systematic review of phage therapy applied to bone and joint infections: an analysis of success rates, treatment modalities and safety","volume":"6","author":"Genevi\u00e8re","year":"2021","journal-title":"EFORT Open Rev"},{"key":"10.1016\/j.jgar.2024.07.007_bib0075","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/cid\/ciy947","article-title":"A systematic and critical review of bacteriophage therapy against multidrug-resistant ESKAPE organisms in humans","volume":"69","author":"El Haddad","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2024.07.007_bib0076","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.virol.2013.05.022","article-title":"Safety analysis of a Russian phage cocktail: from metagenomic analysis to oral application in healthy human subjects","volume":"443","author":"McCallin","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.jgar.2024.07.007_bib0077","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1016\/j.cell.2022.07.003","article-title":"Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation","volume":"185","author":"Federici","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.jgar.2024.07.007_bib0078","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1111\/j.1462-2920.2011.02644.x","article-title":"Intestinal colonization by enteroaggregative Escherichia coli supports long-term bacteriophage replication in mice","volume":"14","author":"Maura","year":"2012","journal-title":"Environ Microbiol"},{"key":"10.1016\/j.jgar.2024.07.007_bib0079","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41586-019-1742-x","article-title":"Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease","volume":"575","author":"Duan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jgar.2024.07.007_bib0080","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1086\/374001","article-title":"Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage phi MR11","volume":"187","author":"Matsuzaki","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jgar.2024.07.007_bib0081","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01879-21","article-title":"Phage activity against planktonic and biofilm Staphylococcus aureus periprosthetic joint infection isolates","volume":"66","author":"Totten","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2024.07.007_bib0082","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jhazmat.2018.10.093","article-title":"Biochar combined with polyvalent phage therapy to mitigate antibiotic resistance pathogenic bacteria vertical transfer risk in an undisturbed soil column system","volume":"365","author":"Sun","year":"2019","journal-title":"J Hazard Mater"},{"key":"10.1016\/j.jgar.2024.07.007_bib0083","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.cell.2022.12.041","article-title":"Bacteriophages inhibit and evade cGAS-like immune function in bacteria","volume":"186","author":"Huiting","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.jgar.2024.07.007_bib0084","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41586-023-06855-2","article-title":"Structural basis of Gabija anti-phage defence and viral immune evasion","volume":"625","author":"Antine","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.jgar.2024.07.007_bib0085","doi-asserted-by":"crossref","first-page":"e01263","DOI":"10.1128\/mSphere.01263-20","article-title":"Genes influencing phage host range in Staphylococcus aureus on a species-wide scale","volume":"6","author":"Moller","year":"2021","journal-title":"mSphere"},{"key":"10.1016\/j.jgar.2024.07.007_bib0086","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1038\/s41596-020-0346-0","article-title":"Standardized bacteriophage purification for personalized phage therapy","volume":"15","author":"Luong","year":"2020","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jgar.2024.07.007_bib0087","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3389\/fcimb.2018.00376","article-title":"Bacteriophage therapy: clinical trials and regulatory hurdles","volume":"8","author":"Furfaro","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jgar.2024.07.007_bib0088","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.tim.2018.09.006","article-title":"Engineering bacteriophages as versatile biologics","volume":"27","author":"Kilcher","year":"2019","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.jgar.2024.07.007_bib0089","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209390","article-title":"Adjunct phage treatment enhances the effectiveness of low antibiotic concentration against Staphylococcus aureus biofilms in vitro","volume":"14","author":"Dickey","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2024.07.007_bib0090","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1080\/22221751.2020.1747950","article-title":"Non-active antibiotic and bacteriophage synergism to successfully treat recurrent urinary tract infection caused by extensively drug-resistant Klebsiella pneumoniae","volume":"9","author":"Bao","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.jgar.2024.07.007_bib0091","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1002\/med.21572","article-title":"Phage therapy: what factors shape phage pharmacokinetics and bioavailability? Systematic and critical review","volume":"39","author":"D\u0105browska","year":"2019","journal-title":"Med Res Rev"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221371652400136X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221371652400136X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T13:22:40Z","timestamp":1734700960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221371652400136X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":91,"alternative-id":["S221371652400136X"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2024.07.007","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phage therapy for bone and joint infections: A comprehensive exploration of challenges, dynamics, and therapeutic prospects","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2024.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}